Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Cardiotoxicity|Breast Cancer|Prevention|Adjuvant|Trastuzumab
Interventions: DRUG: Candesartan
Sponsor: Samsung Medical Center